Peripheral venous catheter collection of immune effector cells and hematopoietic stem cells is feasible and safe in older pediatric patients.
Journal
Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
revised:
28
09
2021
received:
02
09
2021
accepted:
29
09
2021
pubmed:
10
11
2021
medline:
13
4
2022
entrez:
9
11
2021
Statut:
ppublish
Résumé
The Collection of hematopoietic stem cells (HSC) and immune effector cells (IEC) has unique challenges in children. To maintain adequate blood flow, central venous catheters (CVCs) remain the standard of care in many centers, but are associated with procedural risks and increased resource utilization. The goal of this study was to determine feasibility and safety of peripheral venous catheter (PVC) cell collection in older children. Patients and donors requiring venous access with weight >25 kg, age >8 years were screened for PVC collection via 18G PVCs. Those with poor venous access (on history/exam/pre-screening ultrasound) or unable to maintain suitable procedural position were excluded. Comparison was made to CVC collections in a matched patient cohort. Thirty-eight individuals were screened and met age/weight criteria for PVC collection. Five did not have PVC collection attempted due to poor access (n = 4) or behavioral concerns (n = 1). Thirty-three had PVC collection attempt (HSC = 22; IEC = 11) with median age 15.3 year (range 9.7-18.0) and weight 58.5 kg (range 27.9-115.4). Thirty-two of 33 (97%) patients were collected successfully by PVC without adverse events. Comparing PVC to matched CVC collection cohort (n = 18), there was no significant difference in flow rate (48.2 mL/h vs 53.9 mL/h, p = 0.12), collection time (266 min vs 262 min, p = 0.85) or collection efficiency (IEC/CD3 60.9% vs 60.8% p = 0.99; HSC/CD34 53.6% vs 41.3% p = 0.05). PVC collection of HSC and IEC is feasible and safe in older children with comparable collection efficiency to CVC collections. Ultrasound screening may reduce failure rates. PVC collections can reduce the risk of CVC insertions and associated healthcare costs.
Sections du résumé
BACKGROUND
The Collection of hematopoietic stem cells (HSC) and immune effector cells (IEC) has unique challenges in children. To maintain adequate blood flow, central venous catheters (CVCs) remain the standard of care in many centers, but are associated with procedural risks and increased resource utilization. The goal of this study was to determine feasibility and safety of peripheral venous catheter (PVC) cell collection in older children.
METHODS
Patients and donors requiring venous access with weight >25 kg, age >8 years were screened for PVC collection via 18G PVCs. Those with poor venous access (on history/exam/pre-screening ultrasound) or unable to maintain suitable procedural position were excluded. Comparison was made to CVC collections in a matched patient cohort.
RESULTS
Thirty-eight individuals were screened and met age/weight criteria for PVC collection. Five did not have PVC collection attempted due to poor access (n = 4) or behavioral concerns (n = 1). Thirty-three had PVC collection attempt (HSC = 22; IEC = 11) with median age 15.3 year (range 9.7-18.0) and weight 58.5 kg (range 27.9-115.4). Thirty-two of 33 (97%) patients were collected successfully by PVC without adverse events. Comparing PVC to matched CVC collection cohort (n = 18), there was no significant difference in flow rate (48.2 mL/h vs 53.9 mL/h, p = 0.12), collection time (266 min vs 262 min, p = 0.85) or collection efficiency (IEC/CD3 60.9% vs 60.8% p = 0.99; HSC/CD34 53.6% vs 41.3% p = 0.05).
CONCLUSION
PVC collection of HSC and IEC is feasible and safe in older children with comparable collection efficiency to CVC collections. Ultrasound screening may reduce failure rates. PVC collections can reduce the risk of CVC insertions and associated healthcare costs.
Substances chimiques
Antigens, CD34
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3413-3419Informations de copyright
© 2021 AABB.
Références
Carreras E, Dufour C, Mohty M, Kröger N. Indications and results topic leaders: Rafael Duarte and Nicolaus Kröger [internet]. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies [internet]. 7th ed. Switzerland: Springer; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553943/
Wall DA, Krueger J. Chimeric antigen receptor T cell therapy comes to clinical practice. Curr Oncol. 2020;27(S2):S115-23.
Witt V, Peters C. Collection of HSC in children. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies [internet]. 7th ed. Switzerland, Cham (CH): Springer; 2019. Available from: http://www.ncbi.nlm.nih.gov/books/NBK553934/
Pavani G, Fabiano A, Laurent M, Amor F, Cantelli E, Chalumeau A, et al. Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells. Blood Adv. 2021;5(5):1137-53.
Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM, et al. Peripheral blood stem cell donation: an analysis from the international bone marrow transplant registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant. 2001;27(7):689-92.
Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113(15):3604-11.
Passweg JR, Baldomero H, Bregni M, Cesaro S, Dreger P, Duarte RF, et al. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant. 2013 Sep;48(9):1161-7.
Pulsipher MA, Levine JE, Hayashi RJ, Chan KW, Anderson P, Duerst R, et al. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003. Bone Marrow Transplant. 2005 Feb;35(4):361-7.
Padmanabhan A. Cellular collection by apheresis. Transfusion. 2018;58(S1):598-604.
Ghazi S, Alaskar A, Alzahrani M, Damlaj M, Abuelgasim KA, Gmati G, et al. Reducing central venous catheter use in peripheral blood stem cell donation: quality improvement report. BMJ Qual Improv Rep. 2017;6(1):u211975.w4817. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411715/
Empringham B, Chiang KY, Krueger J. Collection of hematopoietic stem cells and immune effector cells in small children. Transfus Apher Sci. 2018 Oct;57(5):614-8.
Babic A, Trigoso E. Cell source and apheresis. In: Kenyon M, Babic A, editors. The European blood and marrow transplantation textbook for nurses: under the auspices of EBMT [internet]. Switzerland, Cham (CH): Springer. p. 2018. Available from: http://www.ncbi.nlm.nih.gov/books/NBK543662/
Ullman AJ, Marsh N, Mihala G, Cooke M, Rickard CM. Complications of central venous access devices: a systematic review. Pediatrics. 2015;136(5):e1331-44.
Styczynski J, Balduzzi A, Gil L, Labopin M, Hamladji R, Marktel S, et al. Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study. Blood. 2011;119(12):2935-42.
Couzin C, Manceau S, Diana J-S, Joseph L, Magnani A, Magrin E, et al. Vascular access for optimal hematopoietic stem cell collection. J Clin Apher. 2021 Feb;36(1):12-9.
Zempsky WT. Optimizing the Management of Peripheral Venous Access Pain in children: evidence, impact, and implementation. Pediatrics. 2008;122(S3):S121-4.
American Academy of Pediatrics. Committee on bioethics. Children as hematopoietic stem cell donors. Pediatrics. 2010;125(2):392-404.
Chan TK, Tipoe GL. The policy statement of the American Academy of Pediatrics - children as hematopoietic stem cell donors - a proposal of modifications for application in the UK. BMC Med Ethics. 2013;31(14):43.
Dong Z, Connolly BL, Ungar WJ, Coyte PC. Cost analysis of peripherally inserted central catheter in pediatric patients. Int J Technol Assess Health Care. 2018;34(1):38-45.
Schindler E, Schears GJ, Hall SR, Yamamoto T. Ultrasound for vascular access in pediatric patients. Pediatr Anesth. 2012;22(10):1002-7.